People Background Check
Find People:

Melissa M Perkins, Age 529504 Neuse Way, Great Falls, VA 22066

Get Report
Known as:
Melissa Mckibben Perkins Melissa J Mckibben
Related to:
James D Mckibben 60 Co Lillis Mckibben

Melissa Perkins Phones & Addresses

9504 Neuse Way, Great Falls, VA 22066 (703) 759-0172

Salinas, CA

Wilmington, DE

219 Cherokee Dr, Erie, PA 16505

Newark, DE

New Haven, CT

9501 Neuse Way, Great Falls, VA 22066

Show more

Mentions for Melissa M Perkins

Career records & work history

Lawyers & Attorneys

Melissa Perkins Photo 1

Melissa Perkins - Lawyer

Specialties:
Bankruptcy, Business Law, Commercial Litigation, Commercial Transactions, Corporate Law, Creditors Rights, Elder Law & Disability Rights, Loan Workouts, Probate, Real Estate Foreclosures
ISLN:
917102217
Admitted:
2002
University:
Albion College, B.A., 1999
Law School:
Wayne State University, J.D., 2002

Medicine Doctors

Melissa A. Perkins

Specialties:
Anesthesiology
Work:
Comprehensive Pain Specialists
353 New Shackle Is Rd STE 122B, Hendersonville, TN 37075
(615) 824-2014 (phone) (615) 824-2081 (fax)
Languages:
English
Description:
Ms. Perkins works in Hendersonville, TN and specializes in Anesthesiology. Ms. Perkins is affiliated with Tristar Centennial Medical Center, TriStar Hendersonville Medical Center and Tristar Medical Center.

Publications & IP owners

Us Patents

Methods And Compositions For Use In Treatment Of Patients With Autoantibody Positive Disease

US Patent:
2009014, Jun 11, 2009
Filed:
Jun 6, 2008
Appl. No.:
12/135025
Inventors:
Marc Chevrier - Collegeville PA, US
William W. Freimuth - Gaithersburg MD, US
Zhenshao Zhong - Potomac MD, US
Daniel Odenheimer - Potomac MD, US
Melissa D. Perkins - Germantown MD, US
Assignee:
Human Genome Sciences, Inc. - Rockville MD
International Classification:
A61K 39/395
A61K 38/16
A61K 38/02
G01N 33/68
A61P 37/06
US Classification:
4241581, 4241731, 514 12, 514 2, 436 86, 4241301
Abstract:
The present invention relates to methods and compositions for use in treatment of patients with autoantibody positive disease. In a specific embodiment, the present invention relates to a method of treating a patient that has an ANA titer of 1:80 or greater and/or greater than or equal to 30 IU/ml of anti-dsDNA antibodies in his/her blood plasma or serum comprising administering a therapeutically effective amount of an immunomodulatory agent, such as an antagonist of Neutrokine-alpha. Additionally provided is a method of reducing the frequency and/or quantity of corticosteroid administration to patients. In preferred embodiments, the patient has systemic lupus erythematosus. Methods for determining if a lupus patient is responding to medical treatment are also provided.

Antibody Formulation

US Patent:
2022017, Jun 9, 2022
Filed:
Nov 5, 2021
Appl. No.:
17/519606
Inventors:
- Brentford, GB
Tristan MARSHALL - Gaithersburg MD, US
Melissa D. PERKINS - McPherson KS, US
Kristin O'BERRY - Gaithersburg MD, US
International Classification:
A61K 39/395
C07K 16/28
C07K 16/24
Abstract:
The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.

Antibody Formulation

US Patent:
2020022, Jul 16, 2020
Filed:
Jan 7, 2020
Appl. No.:
16/736042
Inventors:
- Brentford, GB
Tristan Marshall - Gaithersburg MD, US
Melissa D. Perkins - McPherson KS, US
Kristin O'Berry - Gaithersburg MD, US
International Classification:
A61K 39/395
C07K 16/28
C07K 16/24
Abstract:
The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.

Antibody Formulation

US Patent:
2018028, Oct 11, 2018
Filed:
Jun 13, 2018
Appl. No.:
16/007102
Inventors:
- Brentford, GB
Tristan MARSHALL - Gaithersburg MD, US
Melissa D. PERKINS - McPherson KS, US
Kristin O'BERRY - Gaithersburg MD, US
International Classification:
A61K 39/395
C07K 16/28
C07K 16/24
Abstract:
The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.

Antibody Formulation

US Patent:
2017009, Apr 6, 2017
Filed:
May 15, 2015
Appl. No.:
15/311223
Inventors:
- Brentford, Middlesex, GB
Tristan MARSHALL - Gaithersburg MD, US
Melissa D. PERKINS - McPherson KS, US
Kristen O'BERRY - Gaithersburg MD, US
International Classification:
A61K 39/395
C07K 16/24
C07K 16/28
Abstract:
The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.

Possible Relatives

David J Perkins  Deana A Perkins  Deandre H Perkins  Deanna R Perkins  Damian N Perkins  Aaron B Perkins  Dedrick G Perkins  Melissa E Stamps  Melissa S Stanko  Melissa A Starke 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.